跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion - TGA Drug Approval Details
Approvals
/
TGA
/
Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion
Approved
STANDARD
Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
4383ea7bf746e897
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4383ea7bf746e897
Product Name
Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion
Artg Id
10804
Artg Name
Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-07-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/448d9b3a8a508996e51f7f3f249a088d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a6657db34d5000bad6f38af2bebefa14.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
4383ea7bf746e897
Type
Standard
Back to TGA Approvals